HRTX financials
Heron Therapeutics (HRTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
HRTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $154.90M | $113.56M | -$2.54M | -$20.20M | -0.12 |
| 2024 | $144.28M | $105.64M | -$11.53M | -$13.58M | -0.09 |
| 2023 | $127.04M | $61.94M | -$110.61M | -$110.56M | -0.80 |
| 2022 | $107.67M | $52.80M | -$174.66M | -$182.02M | -1.67 |
| 2021 | $86.35M | $40.33M | -$217.83M | -$220.68M | -2.24 |
| 2020 | $88.64M | $52.45M | -$228.16M | -$227.28M | -2.50 |
- HRTX revenue was $154.90M in fiscal 2025, net income -$20.20M.
Updated 2026-11-10 15:47 UTC